在心力衰竭中进行心交干预
Matthew M Lander1, Michael I Brener2, Kashish Goel3
1Cardiovascular Institute at Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
JACC. Heart failure
|August 23, 2023
概括
在心力衰竭中,随着排气分数的减少,二次 mitrale 排气 (SMR) 会使结果变得更糟. 过导管边缘到边缘修复提供了一个有希望的皮肤间干预,扩大了这些患者的治疗选择.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏衰竭管理的管理
背景情况:
- 在心力衰竭中,减少喷射分数 (HFrEF) 的二次腹 (SMR) 与患者不良结果和生活质量下降有关.
- 以指导方针为导向的医疗疗仍然是SMR的主要治疗方法.
研究的目的:
- 审查跨导管边缘到边缘修复 (TEER) 在HFrEF患者中对SMR的演变作用.
- 确定可能受益于穿皮干预的患者子组.
- 探索TEER在以前未被研究的人群中的潜力.
主要方法:
- 对基准临床试验的分析,重点是针对SMR的TEER.
- 强调多学科的患者选择和管理方法.
- 评估新兴的透导管器械和正在进行的临床试验.
主要成果:
- 具有里程碑意义的试验已经完善了对SMR中TEER患者选择的理解.
- TEER的成功促使其在高级心力衰竭患者群体,包括心脏性休克中进行研究.
- 越来越多的跨导管器件正在扩大治疗选择.
结论:
- 在HFrEF中,TEER是对症状性SMR日益重要的皮肤间干预措施.
- 为了优化TEER的结果,一个多学科的战略至关重要.
- 未来的跨导管创新有望在SMR的HFrEF管理方面取得进一步的进步.
相关概念视频
Mitral Regurgitation III: Medical Management
18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18
Mitral Stenosis III: Medical Management
13
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
13
Mitral Regurgitation IV: Nursing Management
46
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
46
Mitral Stenosis IV: Nursing Management
14
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
14
Mitral Valve Prolapse II: Assessment and Management
22
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
22
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16


